Pathological research output in China and other top-ranking countries: 10-year survey of the literature.

The present study was designed to study the research output in pathology journals from the United States (USA), Japan, Germany, the United Kingdom (UK), France, and China between 2000 and 2009. Articles published in 67 pathology-related journals were retrieved from the PubMed database. US-American publications, which rank first, accounted for 30.9% of the total world's output and for 35.4% in the top 10% journals with impact factor (IF) scores. Chinese publications accounted for 2.8% of a total of 67 journals, and for 2.0% in the top 10% journals with IF scores. Our analysis investigated the research output of these six countries and revealed a positive trend in China for the period 2000-2009. Also, in contrast to other top-ranking countries, our results imply that China's research in the field of pathology falls behind that of the developed countries, and appropriate steps should be taken to improve the role of pathologists in clinical activity and to gear up for high-quality pathological studies.

[1]  Julia Andersen,et al.  Journal impact factor in the era of expanding literature. , 2006, Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi.

[2]  The returning tide: , 2007, The Journal of cell biology.

[3]  Z. Liao,et al.  Scientific publications in cardiology and cardiovasology journals from Chinese authors in various parts of North Asia: 10-year survey of literature. , 2010, International journal of cardiology.

[4]  Olivier Saidi,et al.  Technology Insight: will systems pathology replace the pathologist? , 2007, Nature Clinical Practice Urology.

[5]  José Costa.  Is clinical systems pathology the future of pathology? , 2009, Archives of pathology & laboratory medicine.

[6]  Mahbubur Rahman,et al.  Research articles published in clinical radiology journals: trend of contribution from different countries. , 2005, Academic radiology.

[7]  Ricardo Arencibia-Jorge,et al.  Comparison of SCImago journal rank indicator with journal impact factor , 2008, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[8]  L. Xue.  China: The prizes and pitfalls of progress , 2008, Nature.

[9]  Yihuang Wang,et al.  Life sciences and biotechnology in China , 2007, Philosophical Transactions of the Royal Society B: Biological Sciences.

[10]  Mahbubur Rahman,et al.  Publications in Epidemiology Journals: Japanese perspectives , 2003, Journal of epidemiology.

[11]  C Carl Jaffe.  Pathology and imaging in biomarker development. , 2009, Archives of pathology & laboratory medicine.

[12]  G. Kristiansen,et al.  European and US publications in the 50 highest ranking pathology journals from 2000 to 2006 , 2007, Journal of Clinical Pathology.

[13]  Jiang Gu,et al.  A feasibility study of virtual slides in surgical pathology in China. , 2007, Human pathology.

[14]  K. Goh,et al.  Publications from China: The sleeping giant awakens , 2008, Journal of gastroenterology and hepatology.

[15]  Mohamed H. A. Hassan.  Building Capacity in the Life Sciences in the Developing World , 2007, Cell.

[16]  T. Cheng.  The deteriorating cardiovascular health in China in the past decade. , 2007, International journal of cardiology.

[17]  Japan's share of published research in ophthalmology. , 2003, Japanese journal of ophthalmology.

[18]  Peter A Singer,et al.  How can developing countries harness biotechnology to improve health? , 2007, BMC public health.